Additionally, higher MFI for CD206 or FcγRIIα by tumor-infiltrating CD206+ or FcγRIIα+ cDC1s respectively were linked with a poor clinical outcome (Supplementary Figure 9D). Here, MRC1 is linked to neoplasm.